Peter Schiff

What to think about going into 2015

[youtube cXC4I4Bu3h4] Peter Schiff on CNBC World 12/23/2014 Sign up for my free newsletter: http://www.europac.net/subscribe_free_reports Buy my newest book at http://www.tinyurl.com/RealCrash Friend me on http://www.Facebook.com/PeterSchiff Follow me on http://www.Twitter.com/PeterSchiff […]

Mergers & Acquisitions

Phagelux Announces Acquisition of Novel Delivery Systems

Phagelux Announces Acquisition of Novel Delivery Systems PR Newswire SHANGHAI, Dec. 23, 2014 SHANGHAI , Dec. 23, 2014 /PRNewswire/ — Phagelux, Inc., a leading anti-bacterial company developing phage-based solutions, is pleased to announce the acquisition of several biodegradable polymer delivery systems from Iveria Technologies, Inc., a U.S.-based development company specializing in such technologies. […]

Mergers & Acquisitions

Frontdeal Acquires Aterra Investments’ Interests in Atico Mining Corporation

Frontdeal Acquires Aterra Investments’ Interests in Atico Mining Corporation Canada NewsWire TORONTO, Dec. 23, 2014 TORONTO , Dec. 23, 2014 /CNW/ – Frontdeal Limited (“Frontdeal”) and Aterra Investments Limited (“Aterra”) announce they have entered into a share purchase agreement pursuant to which Frontdeal has acquired all of Aterra’s ownership interest in securities of Atico Mining Corporation (“Atico”), consisting of 10,904,462 common shares of Atico (the “Acquired Shares”), and an aggregate of 4,450,000 warrants to purchase additional common shares of Atico (the “Acquired Warrants”) […]

Stock Analysts

Achillion Gains on Positive Results from its HCV Candidates

Shares of Achillion Pharmaceuticals, Inc. ( ACHN ) gained more than 9% after announcing encouraging results from two studies on its hepatitis C virus (HCV) candidates ACH-3102 and ACH-3422. Achillion announced results from a phase II pilot study evaluating an eight-week treatment of ACH-3102 in combination with Gilead’s ( GILD ) Sovaldi (sofosbuvir) for treatment-naïve genotype 1 HCV patients […]

Stock Analysts

Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA

Pharmacyclics, Inc. ( PCYC ) announced that the FDA is expected to render a final opinion on the supplemental New Drug Application (sNDA) for Imbruvica for patients with Waldenstrom's macroglobulinemia (WM) by Apr 17, 2015. We note that the company had announced that it has submitted the sNDA to the FDA for Imbruvica in Oct 2014. […]

Mergers & Acquisitions

The Intertain Group Limited completes acquisition of leading online casino provider Vera&John

The Intertain Group Limited completes acquisition of leading online casino provider Vera&John Canada NewsWire TORONTO, Dec. 23, 2014 TORONTO , Dec. 23, 2014 /CNW/ – The Intertain Group Limited (“Intertain” or the “Company”) (TSX:IT) is pleased to announce that it has completed its previously announced acquisition of the entire issued share capital of Dumarca Holdings PLC (the “Dumarca Shares”), the Malta-based parent company of the Vera&John group (“Vera&John”) […]

Stock Analysts

SunCoke Energy Unit to Sell Harold Keene Assets for $9.5M

Independent metallurgical coke producer SunCoke Energy Inc. ( SXC ) is working on its strategy of downsizing its coal mining business. The company said that its wholly owned subsidiary, Jewell Resources, Inc., has entered into a definitive agreement to sell 100% of its interest in the Harold Keene coal companies (“HKCC”) to Omega Holdings, LLC (“Omega”) for nearly $9.5 million. […]

Stock Analysts

Atmel-Fingerprint Collaborate for Touch-Sensing Solutions

Leading microcontroller and touch technology solutions provider Atmel Corporation ( ATML ) recently entered into a strategic partnership with Fingerprint Cards AB (FPC) — a leader in fingerprint verification solutions, to bring cutting-edge biometric sensor and touch-screen solutions to smart mobile devices. Through this collaboration, the companies aim to provide secure, biometric touch fingerprint area sensing on high-performance touch screens. […]

Stock Analysts

Bristol-Myers Oncology Drug Opdivo Receives FDA Approval

Bristol-Myers Squibb Company ( BMY ) announced that the FDA has cleared its intravenous human programmed death receptor-1 (PD-1) blocking antibody, Opdivo for the treatment of patients suffering from unresectable or metastatic melanoma and disease progression following Yervoy and, if BRAF V600 mutation positive, a BRAF inhibitor. Opdivo gained accelerated approval for the melanoma indication based on tumor response rate and the durability of response. […]

Stock Analysts

Boeing Gets Commitment for 60 737s from Air China

Commercial aerospace behemoth The Boeing Company ( BA ) received a commitment from Air China for the purchase of 60 737 airplanes including a mix of Next-Generation 737 and 737 MAX. The entire deal is valued at more than $6 billion at list prices. The business partnership between Boeing and China’s flag carrier dates back for more than two decades […]

Stock Analysts

FirstEnergy Steps Up Transmission Projects on Shale Boom

Electric utility provider FirstEnergy Corp. ( FE ) is undertaking new transmission projects worth $100 million and assessing the upgrade of additional systems to cater to the shale gas boom in West Virginia’s Marcellus Shale gas industry. Apart from supporting expansion in the Marcellus Shale gas industry, these investments in transmission projects will also facilitate enhanced electric service reliability for Mon Power customers. […]